In Other News

• Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing

• Direct-to-Patient Genetic Testing Identifies Hereditary Cancer Risk in Survivors

• Telomere Length Abnormalities Linked to Lymphoma Development

• Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia

• Genomic Testing Program Improves Diagnosis of Congenital Hyperinsulinism

• Stool DNA Analysis Tracks Disease Activity in IBD

• Automated Workflow and AI Tool Enhance Latent TB Testing and Risk Stratification

• Ultrasonic Fine-Needle Biopsy Tool Improves Salivary Gland Tumor Diagnosis

• Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

• Biomarker Signals Chemotherapy Resistance in Relapsed Small Cell Lung Cancer

• Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio

• Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response

• FDA-Cleared Viscoelastic Testing System Supports Obstetric Bleeding Management

• FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification

• Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence

• New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides

• Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing

• Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence

• Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing

• Whole-Blood RNA Test Predicts Disease Trajectory and Treatment Response

• Blood-Based Epigenetic Test Predicts GLP-1 Response and Tracks Treatment Effects

• Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response

• Study Links Abnormal Gene Splicing to Treatment Response in Metastatic Kidney Cancer